Seres Therapeutics (Formerly Seres Health, Newco LS21)

Seres Therapeutics (Formerly Seres Health, Newco LS21)

A clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Learn more

Launch date
Employees
Market cap
$146m
Enterprise valuation
$287m (Public information from Sep 2024)
Cambridge Massachusetts (HQ)
Authorizing premium user...